NASDAQ NMS - GLOBAL MARKET · CDIO
+0.00% · +$0.0000 · Vol Not reported
Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc

Biotechnology
$1.98

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CDIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Cardio Diagnostics Holdings Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
2022
Employees
17
Country
US

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.98
Last session
Day high
$1.98
Last session
Day low
$1.98
Last session
Previous close
$1.98
52W high
$2.09
-5.26% from high
52W low
$1.93
31% of range
Market cap
$5.9M
EPS
$-3.5500
Shares out
3M
VWAP
$1.98
Last session
Price history computed in-house
1W
+1.02%
SMA 50 $2.00 · below
SMA 200 $2.00 · below
52W position 31%
Veridion warehouse edge

Warehouse intelligence for CDIO.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CDIO insider activity

Cardio Diagnostics Holdings Inc

Score
Coverage building
Pressure
Net buying
Filings
16
Buys / sells
16 / 0
Net value
$100K
Insiders
4
Named filers
FK
Fung Peter K
Insider
Leadership
BJ
Betts Wendy J
Insider
Leadership
BF
Burton Paul Frederick
Insider
Leadership
Cluster

4 insiders bought in the last 90 days

Net pressure

Net buying: $100K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-04-022026-03-31Fung Peter KInsiderbuy$1.953,2059,513$6KSEC Form 4
2026-04-022026-03-31Betts Wendy JInsiderbuy$1.953,2059,513$6KSEC Form 4
2026-04-022026-03-31Burton Paul FrederickInsiderbuy$1.953,20510,464$6KSEC Form 4
2026-04-022026-03-31Intrater JamesInsiderbuy$1.953,20510,464$6KSEC Form 4
2026-01-062025-12-31Fung Peter KInsiderbuy$2.712,3066,308$6KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 11 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CDIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDIO in this window.
Lobbying spend

CDIO lobbying filings, year to date.

Registered lobbying filings matched to Cardio Diagnostics Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CDIO in this window.
Latest news · CDIO
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CDIO.
Options
Sovereign unlock shows live options positioning for CDIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.